Synergistic and Additive Inhibition of UDP‐Glucuronosyltransferase 1A9 by Endogenous and Foodborne Inhibitors
Basic & Clinical Pharmacology & Toxicology · 2025
DOI: 10.1111/bcpt.14116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2025. Verfasst von Ruixue Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center of Targeted Development of Medicinal Resources (iCTM) & Research Center of Aquatic Organism Conservation and Water Ec…. Hauptthemen laut MEDLINE: Glucuronosyltransferase, Drug Synergism, UDP-Glucuronosyltransferase 1A9, Biphenyl Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Science Research Project of Anhui Provincial Department of Education, Opening Foundation of Provincial Key Laboratory of Biodiversity Study and Ecology Conservation.
Abstract (Originalsprache)
UDP‐glucuronosyltransferases (UGTs) are responsible for inactivation of a variety of drugs, endogenous hormones and environmental toxicants. Chemical inhibitors are a common factor decreasing UGT activities and furtherly inducing health problems. Although simultaneously encountering different inhibitors is readily to occur, no information is available for combined inhibition of UGT. This in vitro study investigates the combined inhibition of human UGT1A9 by endogenous and foodborne inhibitors (magnolol, di‐bromophenols, UDP). J values (the ratio of inhibitory rate to the remaining activity) are analysed to determine the combined inhibition type. The combined inhibition of di‐bromophenols and UDP obeys additive inhibition, in which combined J values equal to the sum of individual J values in alone inhibition assays. Meanwhile, there is a synergistic effect between 2,4‐di‐bromophenol and magnolol with combination index values ranging from 0.10 to 0.85. Further assays indicate that 2,4‐di‐bromophenol decreases IC 50 values for magnolol and vice versa. Kinetic analysis confirms that the two inhibitors and UGT1A9 can form a ternary complex with the inhibition constants of 0.0188 μM (magnolol) and 0.634 (2,4‐di‐bromophenol) μM. In summary, this study demonstrates that besides additive inhibition, synergistic inhibition is a probable occurrence in combined inhibition of UGT. It is suggested that the inhibitors can increase mutual inhibitory effects which deserves attentions in future UGT inhibition related studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Collaborative Innovation Center of Targeted Development of Medicinal Resources (iCTM) & Research Center of Aquatic Organism Conservation and Water Ecosystem Restoration, Anqing Normal University, Anqing, China.
- School of Resources and Environment & Provincial Key Laboratory of Intelligent Quality Monitoring and Soil Fertility Improvement for Farmland, Anqing Normal University, Anqing, China.
ORCID-Profile: Ruixue Li
Förderung
- Natural Science Research Project of Anhui Provincial Department of Education
- Opening Foundation of Provincial Key Laboratory of Biodiversity Study and Ecology Conservation
Zitieren
APA
Li, R., Xiao, L., Li, W., Li, W., Zhao, K., & Zhu, L. (2025). Synergistic and Additive Inhibition of UDP‐Glucuronosyltransferase 1A9 by Endogenous and Foodborne Inhibitors. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.14116
Vancouver
Li R, Xiao L, Li W, Li W, Zhao K, Zhu L. Synergistic and Additive Inhibition of UDP‐Glucuronosyltransferase 1A9 by Endogenous and Foodborne Inhibitors. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.14116
BibTeX
@article{Li2025,
author = {Li, Ruixue and Xiao, Ling and Li, Wenjuan and Li, Wenjing and Zhao, Kuan and Zhu, Liangliang},
title = {Synergistic and Additive Inhibition of UDP‐Glucuronosyltransferase 1A9 by Endogenous and Foodborne Inhibitors},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
doi = {10.1111/bcpt.14116}
}
EUVIMED